AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 527843: 2,4-Dichlorobenzyl ethyl ether

Chemical compound data from PubChem database. IUPAC Name: 2,4-dichloro-1-(ethoxymethyl)benzene. Molecular Formula: C9H10Cl2O. Molecular Weight: 205.08. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance

Background
          Transmission of hepatitis C vims (HCV) is strongly associated with use of contaminated blood products and injection drugs. Other "non-parental" modes of transmission including sexual activity have been increasingly recognized. We examined risk factors for acquiring HCV in patients who were referred to two tertiary care centers and enrolled in an antiviral therapy protocol.
        
        
          Methods
          Interviews of 148 patients were conducted apart from their physician evaluation using a structured questionnaire covering demographics and risk factors for HCV acquisition.
        
        
          Results
          Risk factors (blood products, injection/intranasal drugs, razor blades/ toothbrushes, body/ear piercing, occupational exposure, sexual activity) were identified in 141 (95.3%) of participants; 23 (15.5%) had one (most frequently blood or drug exposure), 41 (27.7%) had two, and 84 (53.4%) had more than two risk factors. No patient reported sexual activity as a sole risk factor. Body piercing accounted for a high number of exposures in women. Men were more likely to have exposure to street drugs but less exposure to blood products than women. Blood product exposure was less common in younger than older HCV patients.
        
        
          Conclusion
          One and often multiple risk factors could be identified in nearly all HCV-infected patients seen in a referral practice. None named sexual transmission as the sole risk factor. The development of a more complete profile of factors contributing to transmission of HCV infection may assist in clinical and preventive efforts. The recognition of the potential presence of multiple risk factors may have important implications in the approach to HCV surveillance, and particularly the use of hierarchical algorithms in the study of risk factors.
NNDSS - Table II. Tuberculosis

NNDSS - Table II. Tuberculosis - 2019.  This Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying WONDER data. Data on United States will exclude counts from US territories. 
Footnote: C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts. Min: Minimum. Max: Maximum. 
* Case counts for reporting year 2018 and 2019 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf 
† Data for TB are displayed quarterly.
Nerve growth factor selectively regulates expression of transcripts encoding ribosomal proteins

Background
          NGF exerts a variety of actions including promotion of neuronal differentiation and survival. The PC12 rat pheochromocytoma cell line has proved valuable for studying how NGF works and has revealed that the NGF mechanism includes regulation of gene expression. Accordingly, we used SAGE (Serial Analysis of Gene Expression) to compare levels of specific transcripts in PC12 cells before and after long-term NGF exposure. Of the approximately 22,000 transcripts detected and quantified, 4% are NGF-regulated by 6-fold or more. Here, we used database information to identify transcripts in our SAGE libraries that encode ribosomal proteins and have compared the effect of NGF on their relative levels of expression.
        
        
          Results
          Among the transcripts detected in our SAGE analysis, 74 were identified as encoding ribosomal proteins. Ribosomal protein transcripts were among the most abundantly expressed and, for naive and NGF-treated PC12 cells, represented 5.2% and 3.5%, respectively, of total transcripts analyzed. Surprisingly, nearly half of ribosomal protein transcripts underwent statistically significant NGF-promoted alterations in relative abundance, with changes of up to 5-fold. Of the changes, approximately 2/3 represented decreases. A time course revealed that the relative abundance of transcripts encoding RPL9 increases within 1 hr of NGF treatment and is maximally elevated by 8 hr.
        
        
          Conclusions
          These data establish that NGF selectively changes expression of ribosomal protein transcripts. These findings raise potential roles for regulation of ribosomal protein transcripts in NGF-promoted withdrawal from the cell cycle and neuronal differentiation and indicate that regulation of individual ribosomal protein transcripts is cell- and stimulus-specific.
2010 CMHS Uniform Reporting System (URS) Output Tables for New York

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
MD COVID-19 - Total Probable Deaths by Date of Death

<b>Note:</b> Starting April 27, 2023 updates change from daily to weekly.

<b>Summary</b>
The cumulative number of probable COVID-19 deaths among Maryland residents, by date of death.

<b>Description</b>
The MD COVID-19 - Total Probable Deaths by Date of Death data layer is a collection of the statewide probable COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by date of death. A death is classified as probable if the person's death certificate notes COVID-19 to be a probable, suspect or presumed cause or condition. Probable deaths are not yet been confirmed by a laboratory test. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Confirmed deaths are available from the MD COVID-19 - Total Confirmed Deaths by Date of Death data layer.

<b>Terms of Use</b>
The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Compound 530115: 1H-Indole-3-acetic acid, 1-(trimethylsilyl)-5-[(trimethylsilyl)oxy]-, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-(1-trimethylsilyl-5-trimethylsilyloxyindol-3-yl)acetate. Molecular Formula: C19H33NO3Si3. Molecular Weight: 407.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400365-T1: [Translated] DEVICE FOR CAVITY PRESERVATION AND PRE-ATOMIZER

Liquid wax passes through an inlet valve (1) leading to a line (2) connected to a pressure regulator (3). The wax then passes through a flow measurement device (4) to a pre-atomization system (14) mixing liquid wax with air under pressure. The air enters via an inlet valve (6) leading to a line (5) connected to filters (7,8), a pressure measurement device (9) and a control valve system (22) with three 5/2-way valves (15,17,21) and two pressure regulators (16,18). The size of the droplets of wax produced by the pre-atomization system may be controlled. The wax mist may be fed through a valve (20), which admits extra air (11), to the spray lance (19).
Compound 527102: Methyl 5-(2-acetamidoethoxyimino)-5-[4-(trifluoromethyl)phenyl]pentanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 5-(2-acetamidoethoxyimino)-5-[4-(trifluoromethyl)phenyl]pentanoate. Molecular Formula: C17H21F3N2O4. Molecular Weight: 374.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Health Insurance Exchanges Monthly Effectuated Enrollment

The Health Insurance Exchanges Monthly Effectuated Enrollment data provide select metrics on monthly effectuated enrollment across the Federally Facilitated Exchange (FFE) and State‑Based Exchanges on the Federal Platform (SBE‑FPs), which both use the federal enrollment platform (HealthCare.gov), as well as State‑Based Exchanges (SBEs) that operate their own eligibility and enrollment platforms.

These metrics include effectuated enrollment counts by state, exchange platform type, year and month.
TANF Contingency Fund Awards

Contingency Funds are additional Federal funds available to States, at their request, when unfavorable economic conditions exist. They are considered provisional payments, according to section 403(b)(3)(A) of the Act. This is because the exact amount of Contingency Funds that the State may actually keep is not determined until after the fiscal year ends, not when payment is made. A State that receives a provisional payment must meet specific spending requirements to keep some or all of the Contingency Funds. Data files are by state and year.

<b>Units of Response: </b>State TANF Programs

<b>Type of Data: </b>Financial

<b>Tribal Data: </b>No

<b>COVID-19 Data: </b>No

<b>Periodicity: </b>Annual

<b>SORN: </b>https://www.federalregister.gov/documents/2018/02/14/2018-03014/privacy-act-of-1974-system-of-records

<b>Data Use Agreement: </b>Unavailable

<b>Data Use Agreement Location: </b>Unavailable

<b>Equity Indicators: </b>Unavailable

<b>Granularity: </b>State

<b>Spatial: </b>United States

<b>Geocoding: </b>State
Uniform Facility Data Set US (UFDS-1997)

<p>The Uniform Facility Data Set (UFDS), formerly the National Drug and Alcohol Treatment Unit Survey or NDATUS, was designed to measure the scope and use of drug abuse treatment services in the United States. The survey collects information from each privately- and publicly-funded facility in the country that provides substance abuse treatment as well as from state-identified facilities that provide other substance abuse services. Data are collected on a number of topics including facility operation, services provided (assessment, therapy, testing, health, continuing care, programs for special groups, transitional services, community outreach, ancillary), type of treatment, facility capacity, numbers of clients, and various client characteristics. The main objective of the UFDS is to produce data that can be used to assess the nature and extent of substance abuse treatment services, to assist in the forecast of treatment resource requirements, to analyze treatment service trends, to conduct national, regional, and state-level comparative analyses of treatment services and utilization, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its on-line equivalent, the Substance Abuse Treatment Facility Locator <a href="http://findtreatment.samhsa.gov">http://findtreatment.samhsa.gov</a>.  Additionally, the UFDS provides information that can be used to design sampling frames for other surveys of substance abuse treatment facilities.This study has 1 Data Set.</p>
Patent AT-E399579-T1: [Translated] SYSTEM FOR USING HIGH-INTENSITY FOCUSED ULTRASOUND TO FORM AN ABLATED AREA OF TISSUE

Apparatus and method for ablating target tissue including a non-linear area of tissue in the left atrium of a patient. The method can include selecting an ablation apparatus having an ablator with a tissue engagement section, penetrating a chest cavity of the patient, and identifying the target tissue. The method can also include positioning the ablation apparatus adjacent to the target tissue so that the tissue engagement section can transfer ablation energy to the target tissue. The method can further include energizing the tissue engagement section with ablation energy in order to create a footprint on the non-linear area of tissue in the left atrium and to reduce an overall mass of excitable tissue in the left atrium.
Patent AT-E401355-T1: [Translated] CURABLE COATINGS WITH LOW PERMEABILITY TO SULFUR CONTAINING GASES

Siloxane cross-linked polyolefins provide for a composition that is more or less impermeable to gaseous sulfur compounds such as hydrogen sulfide providing for a protective coating for various articles of manufacture especially electronic components and a method of protecting various articles of manufacture from the effects of such gaseous sulfur compounds.
CDPHE Composite Selected Health Outcome Dataset (County)

This county geography dataset contains eight selected 2011-2015 health outcome rates calculated at the county geography for all of the counties in Colorado: (Asthma Hospitalizations, Diabetes Hospitalizations, Heart Disease Mortality, Influenza Hospitalizations, Low Weight Birth, Motor Vehicle Accident Mortality, Suicide Mortality, and Teen Fertility).  The rates contained in this dataset represent 2011-2015 5-Year Averages and include the 95% confidence interval for each county rate as well as the Colorado state average.  Published rates that have large confidence intervals should be interpreted with caution.  This dataset is assembled and maintained annually by the Colorado Department of Public Health and Environment.
Compound 529974: Tetrahydrofuran, 3-chloro-2-(2-chloropropyloxy)

Chemical compound data from PubChem database. IUPAC Name: 3-chloro-2-(2-chloropropoxy)oxolane. Molecular Formula: C7H12Cl2O2. Molecular Weight: 199.07. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401412-T1: [Translated] PLANT FOR PRODUCING ALCOHOL

The aim of the invention is to produce alcohol from plant-based raw materials while reducing energy consumption. Said aim is achieved by separating the husk portion of cereals during grinding and feed said husk portion to a dryer (21) which dries distiller's wash as a carrier medium for distiller's wash. The lost heat of said dryer (21) is supplied to the distillation station (15) as process heat. The lost heat of a molecular sieve (45) that drains the raw alcohol is also redirected to the distillation station (15) as process heat.
Compound 529438: 1,4,4-Trimethyltricyclo[5.3.1.02,6]undecan-11-ol

Chemical compound data from PubChem database. IUPAC Name: 1,4,4-trimethyltricyclo[5.3.1.02,6]undecan-11-ol. Molecular Formula: C14H24O. Molecular Weight: 208.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease

NNDSS - TABLE 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease – 2021.  In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 525985: 2-Methyl-5-tridecylthiophene

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-5-tridecylthiophene. Molecular Formula: C18H32S. Molecular Weight: 280.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525909: N,N-Dimethyl-N'-octyl-pivalamidine

Chemical compound data from PubChem database. IUPAC Name: N,N,2,2-tetramethyl-N'-octylpropanimidamide. Molecular Formula: C15H32N2. Molecular Weight: 240.43. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Opinion: The clinical use of selective digestive decontamination

Several recent meta-analyses have shown that the use of SDD can reduce the occurrence of nosocomial pneumonia among ventilated patients in the intensive care unit (ICU) setting. However, the use of SDD has also been demonstrated to increase subsequent patient colonization and infection with antibiotic-resistant bacteria, particularly Gram-positive cocci. Therefore, the routine use of SDD cannot be advocated at the present time. The mortality benefit of SDD appears to occur in surgical/trauma patients, and to be associated primarily with the administration of parenteral antibiotics. This is already an accepted practice in most patients during the perioperative period (eg prophylactic parenteral antibiotics for 24 h). Prolonged decontamination of the aerodigestive tract with topical antimicrobials does not appear to influence outcome, and should not be routinely employed.
COVID-19 State Profile Report - Arizona

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Determinants of blood pH in health and disease

An advanced understanding of acid–base physiology is as central to			 the practice of critical care medicine, as are an understanding of cardiac and			 pulmonary physiology. Intensivists spend much of their time managing problems			 related to fluids, electrolytes, and blood pH. Recent advances in the			 understanding of acid–base physiology have occurred as the result of the			 application of basic physical-chemical principles of aqueous solutions to blood			 plasma. This analysis has revealed three independent variables that regulate pH			 in blood plasma. These variables are carbon dioxide, relative electrolyte			 concentrations, and total weak acid concentrations. All changes in blood pH, in			 health and in disease, occur through changes in these three variables. Clinical			 implications for these findings are also discussed.
Compound 526780: 9-Hydroxy-arachidic, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 9-[tert-butyl(dimethyl)silyl]oxyicosanoate. Molecular Formula: C27H56O3Si. Molecular Weight: 456.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.